http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 이유경 ( You Kyoung Lee ) (검색결과 29 건)
- 무료
- 기관 내 무료
- 유료
-
디지털 리포지터리의 지속가능한 협력 모델로서 하티트러스트 사례 연구
이유경,성윤아,정영미,Lee, You-Kyoung,Sung, Yunah,Jung, Young-Mi 한국도서관정보학회 2016 한국도서관정보학회지 Vol.48 No.1
세계의 많은 기관들은 학술 정보 유통을 위해 디지털 리포지터리들을 구축해왔다. 동시에 디지털 리포지터리들은 증가하는 디지털 자원을 어떻게 장기적으로 보존하고 지속가능한 정보 환경 구축할 것인가의 문제에 직면해 있다. 하티트러스트(HathiTrust) 파트너십은 미국 연구도서관들의 디지털 리포지터리의 지속가능한 협력 모델의 필요성에 의해 시작하여 전 세계의 리포지터리들과의 체결을 통해 점차 확장되고 있다. 이에 본 연구에서는 하티트러스트의 설립배경부터 구축, 운영 및 정책, 현황 및 이용 서비스에 이르는 전반적인 사례와 실질적인 운영 과정 등을 다루었고 또한 하티트러스트의 효과와 앞으로 기대되는 가능성 등을 파트너십 단위 기관의 시각에서 다루고자 하였다. 하티트러스트를 통해 파트너십 기관들은 효과적인 운영 비용, 디지털 콘텐츠의 공동 관리 및 장기 보존, 저작권 관리의 용이성, 접근성 확대 등의 특장점이 있으며, 향후에는 인쇄물의 공동보존서고 운영, 빅데이터 분석 토대 마련 등의 기회를 제공할 것으로 기대된다. A great number of institutions around the world have been building digital repositories to communicate scholarly information. Meanwhile, digital repositories have been struggling with how to preserve increased volume of digital contents for the long term and how to build a sustainable information environment. The HathiTrust partnership was established to meet the need of a sustainable collaborative model of digital repositories in research libraries, mainly in North America, and has been expanded globally by signing with other libraries around the world. This paper is dealt with the establishment, operation and policy, construction status, and user service of the HathiTrust. The results presented in this paper include the benefits and potential opportunities of the HathiTrust as a participating member. Partnership in HathiTrust would allow each member institution to provide more cost-effective operations, shared management and long-term preservation of digital content, ease of copyright management, and increased accessibility. In the future it is expected to provide a shared storage of printed materials and to facilitate a big data research center.
-
글로벌 금융위기와 금융서비스 개방의 관련성에 관한 연구
이유경(You-Kyoung Lee) 한국관세학회 2009 관세학회지 Vol.10 No.3
The global financial crisis really show the effect on the world economy and financial markets around the world. Large financial institutions have collapsed, the world stock markets have fallen, and governments in the developed countries should cope with the situations to rescue their economy and financial systems. Moreover global financial crisis affects the livelihood of almost every country in an interconnected world. In the situation, this paper provides an overview of the global financial crisis and financial service opening. This global financial crisis call into the questions of financial service rules on the GATS. The developed countries which claimed financial service liberalization cope with the financial crisis in the opposite direction of opening that is the financial protectionism. This paper are concerned what the directions of financial opening in the regulation and policy are. This global crisis provides the most radical reshaping of the global financial sector and international financial systems. The purposes of this paper research on the major causes of global crisis firstly and analyze the relation between the financial crisis, the financial service liberalization, or policy in the financial service.
-
이유경(You Kyoung Lee),이상무(Sang Moo Lee) 대한의학유전학회 2011 대한의학유전학회지 Vol.8 No.1
대부분의 의사들은 임상시험을 치료약제개발 후 의료현장에서 사용하기 위해 진행되는 과정으로 생각할 것이다. 실험실에서 개발된 기술이 진단검사로써 도입되기 위해서는 치료약제의 경우와 유사한 임상시험 과정을 거쳐 그 안정성과 유효성에 대한 검증을 필요로 한다. 치료약제의 효과검증에서 가장 우수한 근거를 얻을 수 있는 연구방법은 무작위대조연구 방법이지만, 이를 검체진단검사에 그대로 적용하기는 어렵다. 검체진단검사의 경우 비교연구가 진단정확도의 검증을 위해 현실적으로 사용할 수 있는 연구방법이지만 대상군의 모집 방법과 구분 방법, 질환대상자의 질환 심각도, 참고표준의 선택과 적용, 눈가림 여부 등 여러 요인들이 진단정확도 지표에 직접적인 영향을 주기 때문에, 좋은 근거수준의 연구결과를 얻기 위해서는 이러한 요소들을 고려한 잘 고안된 연구디자인이 중요하다. 또한 검체진단검사는 치료약제의 경우와 달리 결과를 얻기 위한 검사과정이 사용자인 일선 검사실에 의해 계속 생산되어야 하고, 검사의 개발과 발전의 속도가 빠르며, 일선검사실이 최종사용자이자 개발자인 경우가 흔하다는 특성이 있다. 저자들은 이러한 검사의 특성을 고려하여 검사법 자체의 수행능력에 대한 검증으로부터 검사법 성능평가를 위한 질환확진군과 정상군에 대한 비교연구, 일련의 질환의심자 대상의 진단정확도 평가와 임상 효과성 평가, 도입 후 일상감시로 이어지는 임상시험의 진행단계를 제안하고자 한다. Most clinicians understand clinical trials as the evaluation process for new medicine before their use. However, clinical trials can also be applied to laboratory diagnostic tests (LDTs) to verify diagnostic accuracy and efficacy before their clinical laboratory implementation for patients. The clinical trial of LDT has two distinctive characteristics that are different from the case of pharmaceuticals and thus worth special consideration. One of them is the level of evidence. The well-designed randomized controlled trials (RCTs) are known to provide the best evidence to prove the clinical efficacy of any pharmaceutical products. However, RCTs lose practicality when applied to LDTs due to various issues including ethical complications. For this reason, comparative study format is considered more feasible approach for LDTs. In addition pharmaceuticals and LDTs are different in that the user’s intervention is not required for the former but critical to the latter. Moreover, in the case of pharmaceuticals, end-products are produced by manufacturers before being used by clinicians. However, in LDTs, once reagents and instruments are provided by manufacturers, they are first utilized by clinical laboratories to produce test results in order for clinicians to use them later. In other words, when it comes to LDTs, clinical laboratories play the role of manufacturers, providing reliable test results with improved quality assurance. Considering the distinctive characteristics of LDTs, we would like to offer detailed suggestions to successfully perform clinical trials in LDTs, which include analytical performance measures, clinical test performance measures, diagnostic test accuracy measures, clinical effectiveness measures, and post-implementation surveillance.
-
-
-
배양 2 일과 3 일째 배아이식후 체외수정술의 결과에 대한 비교연구
이유경(You Kyoung Lee),이진(Jin Lee),김미영(Mi Young Kim),이여일(Yu Il Lee) 대한산부인과학회 2002 Obstetrics & Gynecology Science Vol.45 No.10
Objective : To compare the clinical outcomes of day 2 embryo tranfer with those of day 3 embryo transfer after In Vitro Fertilization (IVF). Methods : Medical records of 192 patients (217 cases) undergoing IVF-ET at Chonnam National University Hospital from February 1995 to July 2001 were reviewed. The number of cases of the day 2 transfer (D-2) group and the day 3 transfer (D-3) group was 152 and 65, respectively. Clinical characteristics, mean number of fertilized oocytes, frequency of embyo qualities, mean number of embyo transferred, cumulative embryo score (CES) per transfer, pregnancy rate per cycle, clinical pregnancy rate per cycle and implantation rate per transferred embyo were compared between the two groups. Results : In embyo quality, grade I in D-2 group (69.5%) was much more than in D-3 group (52.3%) in number, and grade Ⅲ and Ⅳ in D-3 group (9.7% and 6.2%) was much more than in D-2 group (1.0% and 0.2%). CES was significantly higher in D-3 group than in D-2 group (62.4±40.0 versus 49.1±34.2). However, there were no statistically significant differences between the two groups in number of fertilized oocytes, number of embryo transferred, pregnancy rate, implantation rate and pregnancy outcome. There were also no significant differences between the two groups in implantation and pregnancy rates according to age, under 35 vs over 35 and the presence or absence of previous IVF-ET failure. Conclusion : There were no difference in the pregnancy rate and implantation rate between the two groups. The CES which indicates the quality of embryo was higer in D-3 group than in D-2 group. Since this study did not show the direct effect of better quality of D-3 embryo on implantation rate and pregnancy rate, further investigation should be needed. In addition, further studies about improving culture media for embryonic development and selecting better quality embryos for delayed embryo transfer should be continued.
-
-
-
-
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
